Primary Hyperoxaluria Type 1 (PH1), alanine-glyoxylate aminotransferase deficiency leads to excessive hepatic oxalate production, resulting in progressive renal impairment and multi-organ damage from systemic oxalosis…
enhance treatment response in LAPC. Methods: This is a nonrandomized, single-arm, Phase 1 study for adult patients with histologically confirmed LAPC. The treatment involves a nonconcurrent combination ... personalized…
sublingual powder and inhaled suspensions alongside the Best Available Treatment (BAT). Methods: A Phase 1/2 trial-a phase 1 (open label single arm study) expanded into a phase
action potential. Interestingly, in murine models, the triggering event occurs during phase 1 of the action potential. The objective of this review is to determine how much Ca2+ influx occurs ... during phase 1…
potent oral pan-acetylase inhibitor had also shown significant anti-leukemic signals in early phase studies. In the preclinical study, our group had previously reported synergistic anti-leukemic activity when ... FLT3…
depth the self-management experience among the patients with nasopharyngeal cancer during the phase 1 of identification of the symptoms. Method: Individual semi-structured interviews were held with patients diagnosed…
periods of hospital ward observation. Results: This presentation offers analysis drawn from the Phase 1 MaPSaF workshops. MaPSaF is designed specifically for use in the NHS and provides a view
similar tetanus vaccine vial for the Indian market is proposed and hence the Phase 1 study to validate the dose and the safety of the interventional product was planned ... within 7 days of vaccination was 58.3%…
STEP (Safety, tolerability and Efficacy of Progenza) Trial was a first-in-human, Phase I, randomised, double-blind, placebo-controlled single ascending dose study of Progenza ... relevant serum and urine biomarkers…
STEP (Safety, tolerability and Efficacy of Progenza) Trial was a first-in-human, Phase I, randomised, double-blind, placebo-controlled single ascending dose study of Progenza ... relevant serum and urine biomarkers…
into oncology care has been a challenge since the inception of palliative care programs. Phase 1 oncology clinical trial participants are considered a distinctly vulnerable population. They are at high ... trial and…
into oncology care has been a challenge since the inception of palliative care programs. Phase 1 oncology clinical trial participants are considered a distinctly vulnerable population. They are at high ... trial and…
have collaborations with several companies from foreign countries. We want to evaluate the phase 1 trials which were carried in our clinic between the years 2005 and 2015. The distribution
immune response to Tat Oyi has been characterized in preclinical models. A clinical trial phase I/II has been started for a therapeutic Tat Oyi vaccine application: In a double ... group) received three consecutive…